Satter P
Langenbecks Arch Chir. 1984;364:275-80. doi: 10.1007/BF01823214.
In non-small cell carcinoma with lymph node involvement chemotherapy is able to improve survival as well as surgery and chemotherapy in small-cell carcinoma. In heart valve replacement with bioprosthesis change in procurement and fixation has improved 7-year survival rate from 75-95%. Modern pace makers use breathing frequency and Q-T interval from EKG to adjust cardiac output according to demand. Implantable defibrillators are able to reduce lethality in malignant arrhythmias. Acute myocardial revascularisation cannot prevent an infarct but reduce its extent. In chronic pulmonary artery obstruction endarterectomy is possible in selected cases.
在伴有淋巴结受累的非小细胞癌中，化疗能够提高生存率，这与小细胞癌中的手术和化疗效果相当。在生物假体心脏瓣膜置换中，采购和固定方式的改变已将7年生存率从75%提高到了95%。现代起搏器利用呼吸频率和心电图的Q-T间期根据需求调整心输出量。植入式除颤器能够降低恶性心律失常的致死率。急性心肌血运重建虽无法预防梗死，但可缩小其范围。在慢性肺动脉阻塞中，部分病例可行内膜剥脱术。
